Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues

Detalhes bibliográficos
Autor(a) principal: Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Data de Publicação: 1997
Outros Autores: Salicioni, Ana M., Russo, I. H., Higgy, N. A., Gebrim, Luiz H [UNIFESP], Russo, J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/11600/43247
http://cancerres.aacrjournals.org/content/57/3/378
Resumo: Tamoxifen (TAM) exerts a long-term suppressive effect on human breast cancer cell proliferation on. To determine whether the effects of TAM are mediated by specific gene activation or repression, normal and tumoral human breast tissues obtained before and during TAM treatment were analysed by differential display technique, Total RNA for differential display analysis was obtained from breast tissues from two women with the diagnosis of estrogen receptor-positive stage II (T(2)N(1)M(0)) infiltrating ductal carcinoma, made by incisional biopsy, followed by modified radical mastectomy performed after a 30-day treatment with TAM (20 mg/day), One 202-bp cDNA band, AP5-1, was present in normal and tumoral biopsy samples, but was absent in breast tissue obtained during TAM treatment, and was confirmed by Northern hybridization, which showed a 2.7-kb band in both patients, The differentially expressed cDNA fragment showed 99% homology to Homo sapiens CD36 gene, a glycoprotein that acts as a receptor for the extracellular matrix proteins thrombospondin-1, collagen types I and IV, and oxidized low-density lipoprotein, These results indicate that the down-regulation of CD36 induced by TAM might represent alternative or additional mechanisms of action of this drug affecting the functions of thrombospondin-1, which is involved in hematogenous tumor spread, invasion and angiogenesis, and oxidized low-density lipoprotein, playing a role in inhibition of arteriosclerosis. The multiple functions affected by the down-regulation of CD36 by TAM warrant the need for additional studies.
id UFSP_c1e37bac0baa11e0ab3a70ed1034b234
oai_identifier_str oai:repositorio.unifesp.br:11600/43247
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]Salicioni, Ana M.Russo, I. H.Higgy, N. A.Gebrim, Luiz H [UNIFESP]Russo, J.FOX CHASE CANC CTRUniversidade Federal de São Paulo (UNIFESP)2018-06-15T16:39:14Z2018-06-15T16:39:14Z1997-02-01Cancer Research. Philadelphia: Amer Assoc Cancer Research, v. 57, n. 3, p. 378-381, 1997.0008-5472http://repositorio.unifesp.br/11600/43247http://cancerres.aacrjournals.org/content/57/3/378WOS:A1997WF51700008Tamoxifen (TAM) exerts a long-term suppressive effect on human breast cancer cell proliferation on. To determine whether the effects of TAM are mediated by specific gene activation or repression, normal and tumoral human breast tissues obtained before and during TAM treatment were analysed by differential display technique, Total RNA for differential display analysis was obtained from breast tissues from two women with the diagnosis of estrogen receptor-positive stage II (T(2)N(1)M(0)) infiltrating ductal carcinoma, made by incisional biopsy, followed by modified radical mastectomy performed after a 30-day treatment with TAM (20 mg/day), One 202-bp cDNA band, AP5-1, was present in normal and tumoral biopsy samples, but was absent in breast tissue obtained during TAM treatment, and was confirmed by Northern hybridization, which showed a 2.7-kb band in both patients, The differentially expressed cDNA fragment showed 99% homology to Homo sapiens CD36 gene, a glycoprotein that acts as a receptor for the extracellular matrix proteins thrombospondin-1, collagen types I and IV, and oxidized low-density lipoprotein, These results indicate that the down-regulation of CD36 induced by TAM might represent alternative or additional mechanisms of action of this drug affecting the functions of thrombospondin-1, which is involved in hematogenous tumor spread, invasion and angiogenesis, and oxidized low-density lipoprotein, playing a role in inhibition of arteriosclerosis. The multiple functions affected by the down-regulation of CD36 by TAM warrant the need for additional studies.FOX CHASE CANC CTR,BREAST CANC RES LAB,PHILADELPHIA,PA 19111UNIV FED SAO PAULO,ESCOLA PAULISTA MED,DEPT GYNECOL,MASTROL GRP,SAO PAULO,BRAZILUNIV FED SAO PAULO,ESCOLA PAULISTA MED,DEPT GYNECOL,MASTROL GRP,SAO PAULO,BRAZILWeb of Science378-381engAmer Assoc Cancer ResearchCancer ResearchTamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissuesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/432472021-10-05 15:45:12.597metadata only accessoai:repositorio.unifesp.br:11600/43247Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652021-10-05T18:45:12Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
title Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
spellingShingle Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
title_short Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
title_full Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
title_fullStr Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
title_full_unstemmed Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
title_sort Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
author Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
author_facet Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Salicioni, Ana M.
Russo, I. H.
Higgy, N. A.
Gebrim, Luiz H [UNIFESP]
Russo, J.
author_role author
author2 Salicioni, Ana M.
Russo, I. H.
Higgy, N. A.
Gebrim, Luiz H [UNIFESP]
Russo, J.
author2_role author
author
author
author
author
dc.contributor.institution.none.fl_str_mv FOX CHASE CANC CTR
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Salicioni, Ana M.
Russo, I. H.
Higgy, N. A.
Gebrim, Luiz H [UNIFESP]
Russo, J.
description Tamoxifen (TAM) exerts a long-term suppressive effect on human breast cancer cell proliferation on. To determine whether the effects of TAM are mediated by specific gene activation or repression, normal and tumoral human breast tissues obtained before and during TAM treatment were analysed by differential display technique, Total RNA for differential display analysis was obtained from breast tissues from two women with the diagnosis of estrogen receptor-positive stage II (T(2)N(1)M(0)) infiltrating ductal carcinoma, made by incisional biopsy, followed by modified radical mastectomy performed after a 30-day treatment with TAM (20 mg/day), One 202-bp cDNA band, AP5-1, was present in normal and tumoral biopsy samples, but was absent in breast tissue obtained during TAM treatment, and was confirmed by Northern hybridization, which showed a 2.7-kb band in both patients, The differentially expressed cDNA fragment showed 99% homology to Homo sapiens CD36 gene, a glycoprotein that acts as a receptor for the extracellular matrix proteins thrombospondin-1, collagen types I and IV, and oxidized low-density lipoprotein, These results indicate that the down-regulation of CD36 induced by TAM might represent alternative or additional mechanisms of action of this drug affecting the functions of thrombospondin-1, which is involved in hematogenous tumor spread, invasion and angiogenesis, and oxidized low-density lipoprotein, playing a role in inhibition of arteriosclerosis. The multiple functions affected by the down-regulation of CD36 by TAM warrant the need for additional studies.
publishDate 1997
dc.date.issued.fl_str_mv 1997-02-01
dc.date.accessioned.fl_str_mv 2018-06-15T16:39:14Z
dc.date.available.fl_str_mv 2018-06-15T16:39:14Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Cancer Research. Philadelphia: Amer Assoc Cancer Research, v. 57, n. 3, p. 378-381, 1997.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/11600/43247
http://cancerres.aacrjournals.org/content/57/3/378
dc.identifier.issn.none.fl_str_mv 0008-5472
dc.identifier.wos.none.fl_str_mv WOS:A1997WF51700008
identifier_str_mv Cancer Research. Philadelphia: Amer Assoc Cancer Research, v. 57, n. 3, p. 378-381, 1997.
0008-5472
WOS:A1997WF51700008
url http://repositorio.unifesp.br/11600/43247
http://cancerres.aacrjournals.org/content/57/3/378
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Cancer Research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 378-381
dc.publisher.none.fl_str_mv Amer Assoc Cancer Research
publisher.none.fl_str_mv Amer Assoc Cancer Research
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764115875201024